Withings Unveils Its Most Advanced Smart Scale Yet, Featuring Hypertension Risk Assessment

Highlights from the Latest Release

Recently introduced in Las Vegas, Withings has launched the Body Scan 2, a groundbreaking smart scale that goes beyond traditional models by evaluating over 60 health indicators.

Comprehensive Health Evaluations

The Body Scan 2 provides evaluations that ordinary scales cannot. Utilizing Impedance Cardiography along with a 6-lead ECG, it assesses cardiac performance, responsiveness, and heart age. Furthermore, Withings' exclusive AI model evaluates the risk of hypertension and possible blood sugar level irregularities. It also employs pulse wave velocity to determine arterial flexibility.

An advanced Bioimpedance Spectroscopy (BIS) method is used to assess active cellular mass and metabolic efficiency, with certain metrics pending FDA approval for the Body Scan 2.

As Eric Carreel, the founder and president of Withings, mentioned in a press release, the smart scale provides more biometric data within 90 seconds than any wearable can accumulate over weeks.

In a manner similar to other health-tracking tech, the scale establishes initial baselines and identifies changes from them, offering a Health Trajectory score that reflects overall health status.

Focusing on Hypertension

With the advancement in consumer tech, devices like the Body Scan 2 now offer more convenient means to monitor hypertension, traditionally measured with an arm cuff, through diverse technologies including smartwatches and fitness trackers.

The integrated app provides insights and suggestions to address concerning biomarkers, focusing on enhancing metabolic, cardiovascular, and cell resilience.

The company highlights that the scale's recommendations hold significant value during times of cardiometabolic stress, whether due to lifestyle factors, weight fluctuations, or life stages like menopause.

Equipped with a rechargeable battery, the scale can last up to 15 months per charge.

Price and Launch Details

Subject to FDA approval of its metrics, the Body Scan 2 is set to launch in the second quarter of 2026 with a retail price of $600 in the United States.